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LABORATORY INVESTIGATION
Dietary fatty acid modulates glomerular atrial natriuretic
peptide receptor
MID0RI AWAZU, AIDA YARED, LARRY L. SWIFT, RICHARD L. HOOVER,
and IEKUNI ICHIKAWA
Departments of Pediatrics and Pathology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
Dietary fatty acid modulates glomerular atrial natriuretic peptide
receptor. Modification of dietary fatty acid (FA) has been shown to
affect the incidence of hypertension and coronary artery disease. We
studied whether these effects involve changes in the receptor charac-
teristics of vasoactive substance. Characteristics of atrial natriuretic
peptide (ANP) receptors were examined in glomeruli isolated from rats
fed a diet containing 5% in weight w6, 5% w3, 20% £06, 20% o3
polyunsaturated FA or 20% saturated FA (SFA) for >4 weeks. The FA
composition of phospholipids in isolated glomeruli showed an elevation
in 20:4 w6 (arachidonic acid, AA) in 5% w6, 20% w6 and 20% SFA, and
elevations in 20:5 w3 (eicosapentaenoic acid, EPA) in 5% w3 and 20%
(03 groups. The radioligand binding study revealed: (I) in 20% FA
group, receptor density (Ro, fmol/mg prot) of ANP was significantly
decreased compared to 5% group (262 13, n = 8 to 120 13, n 12)
without changes in equilibrium dissociation constant (KD), (2) among
high FA (20%) groups, type of FA was essential for determining Ro;
higher w6 was associated with a lower ANP Ro (177 11 vs. 103 3
fmol/mg prot, P < 0.05) and KD (0.43 .04 vs. 0.27 .02 flM, P <
0.05). To examine whether the alteration in receptor characterisitics is
mediated by FA, effects of FA were examined in vitro. In cultured
mesangial cells, AA, but not EPA, decreased Ro of ANP receptors
(48.7 4.8% of control, P < 0.05) without affecting KD. AA-induced
down-regulation of ANP receptor was not accompanied by changes in
ANP-induced cGMP generation. These results from ex vivo and in vitro
studies suggest that dietary FA modulates the glomerular C receptor of
ANP. The observed effect of FA on glomerular ANP receptor charac-
teristics raises the possibility of the existence of a novel mechanism
through which dietary FA intake affects the cardiovascular physiology
and pathophysiology through affecting the receptor characterisitcs of
vasoactive substances.
Although still inconclusive, dietary fish oil has been shown to
be beneficial for preventing coronary artery disease and lower-
ing blood pressure. Eicosapentaenoic acid (EPA, C20:5 w3) and
docosahexaenoic acid (DHA, C22:6 o.3) are polyunsaturated
fatty acids (FA) which are considered to be the active agent in
fish oil. w6 FA in vegetable oils, the major derivative of which
is arachidonic acid (AA, C20:4 w6), has also been thought to
lower the blood pressure [1], although recent study in humans
showed negative results [21. Apart from atherosclerotic disease
and hypertension, modification of dietary FA, either addition of
w3 FA or depletion of essential FA, has been shown to affect
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the manifestation of experimental glomerular diseases. These
include nephritis [31, nephrosis [41, ischemialreperfusion injury
[51 and glomerular sclerosis [61.
The mechanism of the effects of dietary FA has largely been
viewed in the context of the availability of AA as substrate for
cyclooxygenase and lipoxygenase, resulting in the production
of prostaglandins and other eicosanoids, which have a variety
of biological actions [7]. However, several lines of evidence
suggest other mechanisms of action. It has been suggested that
FA induces changes in the sensitivity or cellular signaling to
vasoactive substances [8, 9]. Shimokawa and Vanhoutte dem-
onstrated that dietary o3 FA affected the sensitivity of coronary
artery rings to substances which produce endothelium-derived
relaxing factor such as bradykinin and serotonin [8]. The
phosphoinositide turnover was shown to be decreased in cul-
tured vascular smooth muscle cells treated with fish oil [91.
Here we report the existence of yet another potential mecha-
nism through which FA affects the cardiovascular physiology,
namely, via modulation of the receptor characteristics of vaso-
active substances. Glomerular receptor characteristics of atnal
natriuretic peptide (ANP) were studied in rats fed several diets
containing FA, differing in type and quantity. Further, the
mechanisms of the observed phenomenon were examined in
cultured mesangial cells.
Methods
All ex vivo experiments were performed in Munich-Wistar
rats fed one of the dietary regimens shown in Table 1.
A fat-free diet was purchased from ICN Nutritional Biomed-
icals (vitamin-free casein 21.10%, sucrose 58.45%, alphacel,
non-nutritive bulk 16.45%, salt mixture U.S.P. XIV 4.00%, plus
ICN Vitamin Diet Fortification Mixture with choline chloride
6.008 g/kg). The fat-free diet was mixed with corn oil (rich in o6
FA), Menhaden oil (rich in w3 FA), and/or coconut oil (rich in
saturated fatty acid, SFA) to achieve the five different dietary
compositions. The dietary regimen was initiated on 90 to 100 g
rats and continued for 4 to 6 weeks. Diets were changed every
day to minimize peroxidation of FA.
The 5% w6 and 5% o3 diets examined the effect of replace-
ment of a large portion of w6 UFA (corn oil) with (03 UFA
(Menhaden oil). The 20% w3 diet tested whether the results of
5% w3 diet were due to restriction of w6 UFA intake rather than
addition of w6 UFA. Thus, the amount of w6 UFA intake was
comparable between 5% w6 versus 20% w3 diet, yet 20% w3 was
265
266 Awazu et alt Dietary fatly acid modulates ANP receptor
Table 1. Dietary regimens
Diet Base
Lipid
% Composition
5% w6
5% w3
20% w6
20% w3
20% SFA
Fat free diet
Fat free diet
Fat free diet
Fat free diet
Fat free diet
5%
5%
20%
20%
20%
Corn oil (100%)
Corn oil (25%) +
Menhaden oil (75%)
Corn oil (100%)
Corn oil (25%) +
Menhaden oil (75%)
Corn oil (25%) +
coconut oil (75%)
supplemented with w3 UFA. Of note, differences between rats
fed 20% o3 versus 5% co6 may, in part, reflect the high total FA
intake (regardless of the type of FA) of 20% w3. The 20% SFA
diet examined a potentially unique effect of ca6 UFA (corn oil)
per se, which may be separate from the specific effect of w3
UFA (Menhaden oil). For this purpose, 75% of the FA present
in the 20% w6 diet was replaced with SFA in the 20% SFA diet.
Body weight gain and daily total caloric intake among the five
groups were evaluated daily.
Isolation of glorneruli
Glomeruli were isolated from rat kidneys using a method
previously reported [101. In brief, rats were decapitated, exsan-
guinated, and the kidneys removed immediately and placed in
ice-cold phosphate buffered saline (PBS). The cortices were
dissected, minced, and homogenized. The resulting suspension
was passed through three consecutive sieves (stainless steel
ASTM #140, #80, #230). The sieved specimens were then
collected, centrifuged three minutes x 2,000 rpm, and the
supernatant discarded. This washing was repeated three more
times, twice in PBS and the third time in ice-cold Hank's
balanced salt solution (HBSS). After the last centrifugation,
glomeruli from two kidneys were suspended in exactly 10 ml of
HBSS, and 450 1.d aliquot was taken for protein determination
by the method of Lowry [11]. Only preparations consisting of
more than 98% intact isolated glomeruli by light microscopic
examination, were used. All above procedures were carried out
at 4°C. For the binding studies, the glomeruli were suspended in
the final assay buffer of HBSS (in: NaC1 137; KC1 5.4; KH,P04
0.44; Na2HPO4 0.33; MgSO4 0.40; MgC12 0.50; CaC1, 1.25; and
Na2HCO3 4.0; at pH 7.4) containing bovine serum albumin
(BSA) 0.2 g/dl; glucose 5.5 mM; Hepes 10 mM; bacitracin 1 mM
and phenylmethylsulphonylfluoride (PMSF) 1 m.
Mesangial cell culture
Rat mesangial cells were isolated and cultured, using the
method described elsewhere [12]. Cell colonies were subcul-
tured in 60 mm culture dishes, and grown in RPMI 1640,
supplemented with 20% fetal calf serum, penicillin 100 U/mI,
and streptomycin 100 pg/mi. Experiments were carried out on
cells from passages 5 through 8. Cells were treated with 2 pg/ml
arachidonic acid (AA), eicosapentaenoic acid (EPA) or vehicle
(ethanol, final concentration 0.1%) for 16 18 hours. The
incorporation of fatty acids were examined using 3H-AA or
EPA. Some cells with AA were further treated with staurospo-
rine (10—v M) for 60 minutes and control cells with vehicle
(DMSO, 0.01%). After washing with PBS three times, cells
were scraped off from the dishes with rubber policeman and
suspended in 250 m sucrose solution, and homogenized with
Polytron (Beckman, Switzerland) with three 30-second bursts.
After the centrifugation at 200 g for 10 minutes to remove nuclei
and unbroken cells, the supernatant was centrifuged at 40,000 g
for one hour. The pellet was resuspended in HBSS with Hepes
10 m and PMSF 1 m and stored at —70°C until the time of
assay.
Radioligand binding studies
The binding studies were performed as previously reported
[13, 14]. The 1251-labeled rat 1-28 ANP sequence (1251-ANP) and
the homologous unlabeled peptide (Peninsula Laboratories,
Inc., Belmont, California, USA) were used for radioligand
binding studies. For isolated glomerular studies, 25 to 50 M
'251-ANP (specific activity, 1,000 to 1,400 Ci/mmol) and appro-
priate concentrations of unlabeled ANP (50 to 5000 p, final
concentration) were placed into borosiicate glass tubes in a
volume of a 100 jtl, and the reaction was initiated by the
addition of 400 1.d of the glomerular suspension. Incubation was
in an ice-water bath for 120 minutes. Pilot studies showed that
full equilibrium was achieved at 120 minutes. Bound radioac-
tivity was separated from the free within 10 seconds by suction-
filtration through glass microfiber filters (Whatman 934AH,
Whatman Ltd., Mainstone, England, UK), followed by four
washings with ice-cold PBS containing 0.2 gIdi BSA. Nonspe-
cific binding was defined as radioactivity bound in the presence
of saturating concentrations (0.1 JiM) of unlabeled ANP128.
Nonspecific binding was 15 — 20% and 7 — 20% of total bound
ligand in glomeruli and mesangial cells, respectively.
Radioactivity was counted in a gamma counter (1282 Com-
pugamma Gamma Counter, LKB Wallac, Finland) with 75%
efficiency. Characteristics of al adrenoceptor was assessed by
3H-prazosin binding. Incubation buffer was 50 mM Tris-HCI,
pH 7.4. Glomeruli of —2O0 jig were incubated with 0.1 to 5 tiM
3H-prazosin for 30 minutes at 25°C. Non-specific binding was
determined in the presence of 100 jiM phentolamine.
Cyclic GMP (cGMP) determination
Mesangial cells pretreated with AA or vehicle as described
above were preincubated at 37°C for 15 mintes in 400 d assay
buffer [13]. Isobutylmethyixanthine was added in a volume of
50 d (final concentration 1 mM) followed exactly two minutes
later by ANP in 50 jil to achieve concentrations 100 nM; 50 jil
of buffer alone was added for baseline levels. The reaction was
stopped at exactly three minutes by adding 600 pi 10% tn-
chioroacetic acid and cooling to 0°C. The precipitated protein
was sedimented at 2000 g for 15 minutes, and the supernatant
was extracted five times with two volumes of water-saturated
ethyl ether followed by evaporation to complete dryness at 80°C
under a stream of air. The dried samples were resuspended in
500 (ii of 50 m acetate buffer, pH 7.4. The cGMP in 100 jil
aliquots was acetylated and its concentration determined by
radioimmunoassay.
Lipid analysis
Lipids from giomeruli and mesangial cells were extracted
using the Bligh-Dyer method [15]. Phospholipids were sepa-
rated from the total lipid extract by thin layer chromatography
on Whatman K6 plates (Scientific Products, Stone Mountain,
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Georgia, USA) using petroleum ether, ethyl ether, and acetic
acid (80:20:1 vol/vol/vol) as the developing solvent. The phos-
pholipids were scraped from the plate, and the fatty acids
methylated using BF3-methanol [161, extracted with n-hexane,
and analyzed using a Hewlett Packard 5890A gas chromato-
graph equipped with a 6 ft x 2 mm i.d. glass column packed
with 10% SP 2330 on 100/120 Chromosorb W (Supelco, Belle-
fonte, Pennsylvania, USA). The fatty acid methyl esters were
identified by comparison of retention times to those of known
standards. Data are expressed as percent of total fatty acids.
Individual phospholipid classes were separated on Absorbosil
HPTLC plates (Alitech Associates, Inc., Deerfield, Illinois,
USA) developed in ethyl acetate, n-propanol, chloroform,
methanol, and 0.25% KC1 (25:25:L25: 13:9). The phospholipid
classes were scraped from the plate after visualization with
iodine vapors, eluted from the gel [17], and lipid phosphorus
was assayed by the method of Bartlett [181.
Protein kinase C (PKC) activity
Following anesthesia, kidneys were perfused with 50 ml of
ice-cold oxygenated phosphate buffer saline with 18 gauge
needle from the aorta and were harvested for protein kinase C
assay. Glomeruli were resuspended in 2 ml of ice-cold solution
containing (in mM) 20 Tris, pH 7.5, 0.5 EGTA, 0.5 EDTA, 2
PMSF, 0.5 benzamidine and leupeptin 25 g/ml (buffer A), and
homogenized with a sonicator. These homogenates were cen-
trifuged at 105,000 g for one hour, and the supernatants used as
the soluble fraction. The pellets were rehomogenized in 1 ml
buffer A containing 0.1% Triton X-loO and sonicated. These
second homogenates were centrifuged at 105,000 g for one hour
and the supernatants used as the particulate fraction. The
protein concentration was assayed by the method of Lowry et
al [11]. PKC activity was determined by measuring the incor-
poration of [y-32P]ATP into PKC specific peptide (Amersham
International plc, UK). Protein kinase C activity was defined as
the difference between the activity measured with Ca2 in the
presence and absence of PMA plus phosphatidylserine. The
final reaction volume of 75 d contained 50 mrvi Tris HC1, pH
7.5, 15 m Mg-acetate, 0.67 mole% phosphatidylserine, 2 tg/m1
PMA, 75 j.g/ml peptide, 50 JLM [32PIATP (30 Ci/mmol; New
England Nuclear, Boston, Massachusetts, USA) and 5 — 10 g
sample. The incubation was for 15 minutes at 25°C. The
reaction was terminated by the addition of 1 ml of ice-cold 25%
trichloroacetic acid and the precipitate collected by filtration
over a Millipore filter (0.45 tm). The reaction tubes were
washed with three 4-ml washes of trichloroacetic acid with the
contents applied to the filter. Filters were then dried and
dissolved in scintillation fluid and counted on a liquid scintilla-
tion counter. Enzyme activity was linear for —30 minutes under
all conditions of assay employed. Protein kinase C activity in
subcellular fractions of crude homogenates assayed as above
was in the same range as that found with the method previously
reported using histone (Type III-S) following DEAE cellulose
chromatography of the fractions [19]. Further, the cross-reac-
tivity of this peptide with cAMP kinase was only 8%, while it
was 50% in the case of histone. Accordingly, all subsequent
assays were performed as above.
Radioreceptor assay
In animals which underwent receptor binding studies, plasma
ANP levels were determined as described previously [201. Rats
were decapitated and blood was collected by exsanguination
into an ice-cold EDTA containing tube, centrifuged at 4°C and
stored at —70°C until the time of assay. Assay was performed as
previously reported [20]. Briefly, 15 tl of sample or 25 d of
standard ANP was incubated for 16 hours at 0°C with 45 .d of
glomerular microsomes (—2 mg/dl prot). '251-ANP (20,000 to
15,000 cpm) was then added to each tube in a volume of 20 d
and incubation was continued for six hours. The separation of
the receptor-bound and free peptide was performed by suction-
filtration.
Calculations and statistics
Binding data were analyzed by the LIGAND program [21].
Unpaired t-tests, analysis of variance, nonparametric Kruskal-
Wallis and Wilcoxon rank sum tests were used as appropriate.
Statistical significance was determined as P < 0.05.
Results
Ex vivo study
Although the experimental diets were given ad libitum,
caloric intake and body weight gain were not statistically
different among the rats fed diets containing 5% o6, 5% w3, 20%
w6,20%o3FAor2O%SFA(59±2,61
1 Cal/day, 3.2 0.4, 3.2 0.5, 3.3 0.3, 3.1 0.3, 3.0 0.4
g/day, respectively). Therefore, although not measured, the
20% group consumed less protein or carbohydrate.
The quantitation of FA content of phospholipids (PL) in
glomeruli isolated from rats fed for four or more weeks revealed
a significantly higher 20:4 w6 (AA) and lower 20:5 u3 (EPA)
content in 5% w6, 20% w6 and 20% SFA than 5% o3 or 20% w3
fed animals (Table 2). Although the composition of FA is similar
among 5% w6, 20% w6 and 20% SFA, total phospholipid (PL)
was significantly higher in 20% w6 and 20% SFA than 5% u6.
Thus, absolute AA in PL is higher in 20% w6 and 20% SFA than
5% w6. In contrast, there was no difference in absolute EPA in
PL between 5% w3 and 20% a3.
Table 3 summarizes the result of ANP radioligand binding
study in glomeruli isolated from five experimental groups of
rats. Rats fed 5% FA, as compared to rats fed 20% FA, had a
significantly higher density (Ro) of ANP binding site (262 13
vs. 120 13 fmol/mg prot, P < 0.05) without a difference in
equilibrium dissociation constant (KD) (0.35 .03 vs. 0.29
.04 nM, NS). Within the 20% FA fed groups, w6 rats had lower
Ro and KD than (03 rats (P < 0.05). This difference between o3
and w6 was not seen in 5% FA rats.
To examine whether different ANP binding among the five
FA groups is due to plasma ANP, its level was measured. There
was no difference among the groups (53.7 1.7, 58.3 4.1,
50.8 12.2, 57.7 9.1, 54,3 13.1 p, respectively).
The results of 3H-prazosin binding assay are shown in Table
4. Rats fed 5% FA, as compared to rats fed 20% FA, had a
lower Ro of al (90 8 vs. 181 16 fmol/mg prot, P <0.05) and
KD (0.10 .02 vs. 0.27 .06 flM, NS). Within the 20% FA fed
groups, o6 rats had higher Ro than u3 rats (P <0.05). Again,
there was no difference between w3 and w6 in 5% FA groups.
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Table 2. Fatty acid content of phospholipid in isolated glomeruli from rats fed different FA diets
5% w6 5% co3 20% w6 20% (03 20% SFA
Total PL isg/mgprot 118.7 20.2 99.7 8.0 169.0 6.2 120.1 12.7 161.7 12.2
Fatty acid %
16:0 24.4 1.8 27.0 3.9 20.6 0.7 23.5 1.6 21.9 2.3
16:1 1.6 0.5 2.0 0.4 0.2 0.2 3.0 1.3 0
18:0 21.6 1.1 21.1 1.5 22.0 1.8 20.9 1.8 21.1 1.0
18:1 10.0 1.6 12.1 2.5 7.7 0.6 9.0 1.0 7.0 0.7
18:2 11.2 0.7 13.1 0.3 17.3 0.4 15.7 0.4 13.2 0.5
20:4 w6 29,1 2.2 14.3 0.3 30.3 0.9 14.8 1.2 33.1 1.1
20:5 w3 0 6.6 0.3 0 8.2 0.6 0
Values represent mean SE; Number of samples: 3 rats in 5% group, 4 rats in 20% group for total PL, 3 rats in each groupfor fatty acid
composition.
Table 3. ANP receptor characteristics in glomeruli isolated from rats fed dufferent fatty acid diets
Experimental groups 5% &i6 5% a3 20% w6 20% o3 209'o SFA
Rofmollmgprot 270 19 254 21 103 3 177 II 81 4
KD nM 0.39 0.03 0.31 0.03 0.27 0.02 0.43 0.04 0.15 0.02
Values are expressed as mean SE of 4 rats in each group. Abbreviations are: 5% w6, rats fed 5% w6 fatty acid diet; SFA, saturated fatty acid;
Ro, receptor density; K0, equilibrium dissociation constant.
Table 4. Glomerular a! adrenoceptor characteristics in rats fed different fatty acid diet
Experimental groups 5% w6 5% w3 20% o'6 20% w3 20% SFA
Rofmol/mgprot 76 8 105 11 192 12 126 11 226 31
K0 flM 0.12 0.03 0.09 0.01 0.39 0.12 0.26 0.10 0.17 0.02
Values are expressed as mean SE of 4 rats in each group. Abbreviations are: 5% (06, rats fed 5% w6 fatty acid diet; SFA, saturated fatty acid;
Ro, receptor density; K0, equilibrium dissociation constant.
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Table 5. Protein kinase C activity in glomeruli isolated from rats fed
different fatty acid diets
Experimental groups 5% aj6 20% w6
Total activity 135.3 14.7 249.8 34,4a
pmollmin/mg prot
% Particulate 23.8 3.1 21.3 4.8
Specific activity
pmol/min/mg prot
Soluble 166.6 24.2 326.9 53.4k
Particulate 75.9 9.9 127.8 21.5k'
Values are expressed as mean SE of 8 rats in each group.
Abbreviations are: 5% o6, rats fed 5% w6 fatty acid diet. Total activity
is calculated from activity in the soluble plus particulate fraction. P <
0.05
Thus, when the rats were on 5% FA diet, the type of FA did
not affect the receptor characteristics. On the other hand, when
FA intake was high, w6 FA diet was associated with low ANP
and high al receptor density.
To test the possibility that these changes in ANP receptor
characteristics induced by FA are mediated by changes in
protein kinase C (PKC) activity, PKC activity was measured in
isolated glomeruli from rats fed 5% w6 or 20% w6 (Table 5).
Collectively, both soluble (326.9 53.4 vs. 166.6 242
pmol/minlmg prot) and particulate fractions of PKC activity
(127.8 21.5 vs. 75.9 9.9 pmollmin/mg prot) were signifi-
cantly higher in 20% w6 than 5% w6.
In vitro study
To examine whether the alterations in receptor characteris-
tics were caused by the dietary fatty acids, cultured mesangial
60
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0
Fig. 1. Incorporation of arachidonic acid into cultured mesangial
cells. 3H-arachidonic acid was incubated for indicated period of time
and the incorporation into each phospholipid components was as-
sessed. Symbols are: (•) P1, phosphatidylinositol; (0) PE, phosphati-
dylethanolamine; (0) PS, phosphatidylserine; () PC, phosphatidyl-
choline; (•) Sph, sphingomyelin.
cells were incubated with AA or EPA (2 pg/ml). As shown in
Figure 1, maximal incorporation occurred in six hours and
remained constant for at least 24 hours. The FA were predom-
inantly incorporated into phospholipids. There was very little
difference in the patterns seen with AA or EPA. In regards to
0 10 20
Time, hours
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Experimental groups CON AA EPA
Ro % 100 0 48.7 4.8a 88.6 6.6
KD flM 0.17 0.02 0.14 0.04 0.18 0.06
the specific phospholipids, the FAs were preferentially taken up
by phophatidylinosytol (P1) followed by phosphatidylethanol-
amine (PE). Incorporation into phosphatidylserine (PS), phos-
phatidyicholine (PC) and Sph was comparatively minor. There-
fore, all the subsequent experiments were performed at 16 — 18
hours of incubation. Table 6 shows the results of ANP binding
in mesangial cells. AA down-regulated Ro on average to 48.7%
of control (P < 0.05). KD was not affected (0.14 .04 vs. 0.17
.02 nM). Although EPA tended to decrease Ro (88.6 6.6%
of control), it did not reach statistical significance.
We also examined whether changes in ANP binding are
accompanied by altered ANP-induced cGMP generation (Fig.
2). cGMP generation was comparable between cells treated
with either vehicle or AA during both baseline condition (0.60
0.04 vs. 0.59 0.05 pmol/mg prot) and after incubation with
ANP l0 NI (87.3 14.2 vs. 84.0 8.2 pmol/mg prot).
To test further the possible role of PKC activity in AA-
induced down-regulation of ANP receptor, a PKC inhibitor,
staurosporine, was incubated with the cells pretreated with AA.
As shown in Table 7, staurosporine completely abolished the
AA-induced down-regulation of ANP binding sites (Ro: 108.2
4.8 vs. 100 0%, NS).
Discussion
The present study demonstrates that characteristics of gb-
merular atrial natriuretic peptide receptor and al adrenoceptor
are different among rats fed different amounts and types of fatty
acid. Thus, rats fed 20% FA diet groups had lower density of
Experimental groups CON AA + staurosporine
Ro % 100 0 108.2 4.8
flM 0.11 0.02 0.09 0.02
gbomerular ANP binding sites and higher at than 5% groups.
Among 20% groups, rats on the w6 diet had lower density of
ANP and higher density of at adrenoceptor than those on the
w3 diet. It is known that there are at least two subtypes of ANP
receptors, one clearance receptor (C receptor), and the other B
receptor, which possess intrinsic guanylate cyclase activity [22,
231. Since the C receptor consists of more than 80% of total
receptor density in glomeruli [23], the observed differences in
ANP receptors are considered to largely reflect the changes in
C receptor. Glomerular ANP C receptor has been shown to be
down-regulated by circulating ANP [24], which is thought to be
caused by prior occupancy by endogenous ANP. In the present
study, the circulating level of ANP was not different among the
rats fed a different FA diet. Therefore, the alteration in glomer-
ular ANP binding is not due to different plasma ANP levels
among FA diet groups.
In our ex vivo studies the dietary regimen to control caloric
intake caused, by design, variable amounts of non-fatty acid
nutrients consumed by different animal groups. To examine
whether the alterations in receptor characteristics were at least
in part caused by fatty acid, we aimed to duplicate the phenom-
enon in vitro. Since the cultured mesangial cells maintained in
our laboratory express ANP binding sites but not at, we
focused on ANP receptors for the subsequent studies. We
demonstrated that AA down-regulated ANP binding in cultured
mesangial cells. Fatty acids were well incorporated at the time
of study primarily into P1 and PE.
There are several factors known to modulate ANP receptor
density other than ambient ANP. We have previously shown
that renal denervation increases glomerular ANP receptors as
well as cGMP production [13]. Other studies reported down-
regulation of ANP receptors by vasoconstrictors such as angio-
tensin II or vasopressin in cultured vascular smooth muscle
cells [25, 26]. The present study demonstrates that FA can also
modulate vascular ANP receptors. Of interest, in this regard,
are recent in vitro and ex vivo experimental findings by several
groups of investigators. Hirata et al showed that ANP receptors
could be down-regulated by a PKC activator, tetradecanoyl
phorbol acetate, in cultured smooth muscle cells, in association
with decreased cGMP generation [27]. On the other hand,
arachidonic acid and other unsaturated FA have been shown to
activate PKC in vitro [28], and it has also been demonstrated
that dietary FA modulates protein kinase C activity ex vivo
[29]. Thus, activation of PKC was observed in epidermal cells
isolated from mice receiving high-fat diet [29]. Further, Craven
et a! demonstrated that w6 FA activated PKC in colonic
epithelial cells through both a direct intracellular effect and
through an action on the cell membrane, resulting in release of
Table 6. ANP receptor characteristics in cultured mesangial cells
treated with AA or EPA
Table 7. ANP receptor characteristics in cultured mesangial cells
treated with AA and staurosporine
Values are expressed as mean SE of 4 experiments in each group.
Abbreviations are: CON, control cells; AA, arachidonic acid; Ro,
receptor density; KD equilibrium dissociation constant.
1
Values are expressed as mean SE of 4 experiments in each group.
Abbreviations are: CON, control cells; AA, arachidonic acid; EPA,
eicosapentaenoic acid; Ro, receptor density; KD, equilibrium dissocia-
tion constant.
a P < 0.05
100
80
60
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Baseline ANP
Fig. 2. Cyclic GMP generation in cultured mesangial cells. Symbols
are: (0) CON, control cells; () AA; cells treated with 2 tg/ml of
arachidonic acid.
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diacylglycerol [19]. We therefore examined whether the glomer-
ular PKC activity was affected in glomeruli isolated from rats
fed 5% and 20% w6 FA, in which ANP receptors had twofold
difference in density. Both soluble and particulate PKC activity
were elevated in glomeruli isolated from 20% o6 compared to
5% group. The functional consequences of altered PKC activity
in rats fed different AA diet was further tested in cultured
mesangial cells. PKC inhibitor, staurosporine, completely re-
versed the down-regulation of ANP receptors by AA in mesan-
gial cells, suggesting that the observed activation of PKC was
functionally significant in affecting the ANP receptor character-
istics. However, further studies are needed to demonstrate the
increase in PKC substrate phosphorylation or the inhibition of
ANP down-regulation with more specific PKC inhibitor. In this
regard, it was surprising that ANP-induced cGMP generation
was not affected by FA. Previous studies demonstrated a
decreased cGMP production as well as ANP binding in smooth
muscle cells by PKC activator, phorbol ester [26]. Perhaps FA
preferentially activates subspecies of PKC which might down-
regulate only C-receptor. Also, the mechanisms underlying the
FA-induced activation of PKC remain to be elucidated. Al-
though direct or indirect stimulation through increasing diacyl-
glycerol has been reported, it could be secondary to arachidonic
acid metabolites such as prostaglandins or thromboxanes.
Although the present study suggests the role of PKC in the
FA-induced down-regulation of ANP receptors, it needs to be
confirmed and also does not negate the other possible mecha-
nisms. There remains a possibility that a change in membrane
fluidity also contributes to the change in receptor characteris-
tics. Cis-unsaturated fatty acids have been reported to change
the physical properties of biological membranes by changing
lipid structure [30] and membrane-cytoskeletal interactions
[31]. It is conceivable that changes in surface receptor process-
ing affect the binding characteristics. It was shown previously
that dietary FA modulates the receptor characteristics of other
vasoactive substances. For example, we have found that high
FA diet increases the affinity of glomerular angiotensin II
receptors without affecting density (unpublished observation).
Furthermore, angiotensin II receptors are not modulated by
PKC in mesangial cells [32]. FA also affects the receptor
density of a! adrenoceptors in glomeruli. Shimokawa and
Vanhoutte demonstrated dietary o3 FA augments endothelium-
dependent relaxations in porcine coronary arteries, which was
at least in part due to the augmented release of endothelium-
derived relaxing factors secondary to receptor changes of
bradykinin or serotinin [8].
The physiological or pathophysiological significance of the
present study needs to be clarified. We have demonstrated
alterations in glomerular total ANP receptor density by dietary
FA, which reflect changes in C receptor. On the other hand,
cGMP generation was not altered in cells treated with AA,
indicating that B receptor having intrinsic guanylate cyclase
activity is not modified. Although the function of C receptor had
been considered as a buffer system for the receptor-ligand
interaction, recent studies demonstrated activation of cellular
signaling such as inhibition of adenylate cyclase or activation of
phospholipase C by C receptor [33, 34]. Also, studies by Cahill
and Hassid suggest its potential role in inhibition of mitogenesis
and proliferation [35]. Relevant to our observation are the
preliminary observations by Schmitz et al that single nephron
glomerular filtration rate and plasma flow were heightened in
rats fed 03 FA diet when compared to w6 or SFA group [36].
Therefore, it appears reasonable to speculate that the observed
effects of FA on glomerular ANP and a! adrenoceptors have
functional roles, that is, modulation of renal perfusion and
filtration.
In summary, the present study suggests that dietary fatty acid
modulates the characteristics of glomerular ANP receptors.
The change in receptors of various vasoactive substances may
be one of the mechanisms by which FA alters the vascular
resistance. Moreover, given the recently accumulating evi-
dence to indicate that various vasoactive substances have the
capability to regulate cell proliferation, it is also conceivable
that the FA-dependent receptor characteristics may also par-
ticipate in determining the susceptibility to various injuries.
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